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The effect of increasing pulmonary endothelial cGMP
concentration on endothelial function in acute lung
injury appears to depend on 1) the presence of specific
cGMP targets, 2) intracellular cGMP compartmentaliza-
tion and 3) the timing of the increase in cGMP relative to
the injury onset [1-4]. For example, we recently showed
that pretreatment of pulmonary artery endothelial mon-
olayers with 8pCPT-cGMP attenuated oxidant-induced
barrier dysfunction by a cGMP-dependent kinase-1
(cGKI)-dependent mechanism [1,2]. More recently, how-
ever, we found that the increase in endogenous lung
cGMP resulting from increased NO production in a venti-
lator-induced lung injury (VILI) mouse model caused
lung endothelial barrier dysfunction [4]. The injurious
effect of sGC-derived cGMP in VILI was mediated by the
simultaneous generation of phosphodiesterase 2A
(PDE2A), which was stimulated by cGMP to hydrolyze
cAMP. Interestingly, in the same model, pretreatment
with BAY 41-2272 (1.5 μM) to stimulate sGC before inju-
rious tidal volume ventilation attenuated VILI.
Recent evidence suggests that endothelial apoptosis may
contribute to VILI [5] so we wondered if the protective
effect of increasing lung endothelial cGMP before injury
could be mediated by an anti-apoptotic effect of cGMP
signalling. Mouse lung microvascular endothelial cells
(MLMVEC) were isolated and purified by flow cytometry
and shown to express cGK1 by Western blot and phos-
phorylation of VASP Ser235. A 6 hr pretreatment with
8pCPT-cGMP (50 μM), significantly attenuated H2O2-
induced cell death assessed by flow cytometry (Annexin-,
7AAD-) and nuclear condensation. A similar protection
was not observed in human pulmonary artery endothelial
cells (HPAEC) which lack cGK1 expression in vitro. Resto-
ration of cGK1 expression in HPAEC resulted in cGMP-
mediated protection against oxidant cell death suggesting
a cGK1-mediated effect. To determine if this protective
effect was upstream of apoptotic signaling, MLMVEC
from C57BL6 mice were treated with 8p-CPT-cGMP (50
uM) before exposure to increasing concentrations of
H2O2. The extracellular H2O2 concentration ([H2O2]ext)
was continuously measured with a H2O2 electrode. Com-
pared with untreated cells, wildtype MLMVEC pre-treated
with 8p-CPT-cGMP for 2 or 4 hrs (but not 30 min) signif-
icantly decreased the maximal Δ[H2O2]ext by 33 ± 11, 32 ±
10 and 25 ± 10% in cells exposed to 20, 50, and 100 μM
H2O2, respectively (N = 8, P < 0.01). Consistent with this
effect, 8pCPT-cGMP pretreatment attenuated H2O2-
induced H2DCF fluorescence as well as p38MAPK and
Akt phosphorylation suggesting that intracellular H2O2
concentration was also decreased. MLMVEC isolated from
cGK1-/- mice failed to enhance H2O2 uptake suggesting
cGK1-mediated signaling was responsible. An assessment
of the major H2O2 degrading enzyme systems revealed a
significant cGMP-mediated increase in catalase expression
without an increase in catalase mRNA suggesting a post-
translational effect.
We conclude that the effects of cGMP signalling on lung
endothelial function in acute lung injury are complex and
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include both injurious and protective mechanisms
depending on the specific downstream signalling path-
ways that are present. Activation of lung microvascular
endothelial cell cGK1 by cGMP protects against oxidant-
mediated cell death possibly through an increase in
endothelial antioxidant function.
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